학술논문
Elranatamab, a BCMA Targeted T-Cell Engaging Bispecific Antibody, Induces Durable Clinical and Molecular Responses for Patients with Relapsed or Refractory Multiple Myeloma
Document Type
Abstract
Author
Raje, Noopur; Bahlis, Nizar Jacques; Costello, Caitlin; Dholaria, Bhagirathbhai; Solh, Melhem; Levy, Moshe Yair; Tomasson, Michael H ; Damore, Michael A. ; Jiang, Sibo ; Basu, Cynthia ; Skoura, Athanasia ; Chan, Edward M ; Trudel, Suzanne; Jakubowiak, Andrzej ; Chu, Michael P ; Gasparetto, Cristina J.; Dalovisio, Andrew P.; Sebag, Michael; Lesokhin, Alexander M
Source
In Blood 15 November 2022 140 Supplement 1:388-390
Subject
Language
ISSN
0006-4971